These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1579074)

  • 1. [Clinical evaluation of drugs].
    Wasielewski S
    Med Monatsschr Pharm; 1992 Feb; 15(2):34. PubMed ID: 1579074
    [No Abstract]   [Full Text] [Related]  

  • 2. How experimental drugs are tested in humans.
    Flieger K
    Pediatr Infect Dis J; 1989 Mar; 8(3):160-2. PubMed ID: 2710587
    [No Abstract]   [Full Text] [Related]  

  • 3. [Testing of drugs in humans. Current responsibilities and problems].
    Weihrauch TR; Gunselmann W
    Fortschr Med; 1989 Feb; 107(5):124-8. PubMed ID: 2651250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized assessment of drug-adverse reaction associations--rationale and experience.
    Venulet J; Ciucci A; Berneker GC
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):381-8. PubMed ID: 7450930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving how we evaluate the toxicity of approved drugs.
    Reidenberg MM
    Clin Pharmacol Ther; 2006 Jul; 80(1):1-6. PubMed ID: 16815311
    [No Abstract]   [Full Text] [Related]  

  • 6. Panel discussion on clinical trials: registration of side-effects.
    Peltola P
    Rheumatol Rehabil; 1978; Suppl():134. PubMed ID: 364606
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of new drugs].
    Lewis PJ
    Rev Prat; 1982 Sep; 32(41-42):2649-50 passim. PubMed ID: 7146802
    [No Abstract]   [Full Text] [Related]  

  • 8. [General modality for evaluation of drugs in pediatry].
    Autret E
    Arch Fr Pediatr; 1990 Nov; 47(9):627-8. PubMed ID: 2078119
    [No Abstract]   [Full Text] [Related]  

  • 9. [Methods for clinical study of antineoplastic drugs].
    Lichinitser MR
    Vopr Onkol; 1986; 32(8):93-8. PubMed ID: 3765515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical drug trials. 1: The 4 phases of clinical trials].
    Gleiter CH; Bieck PR
    Fortschr Med; 1991 Feb; 109(5):136-7. PubMed ID: 2045036
    [No Abstract]   [Full Text] [Related]  

  • 11. Methodology of clinical trials on new drugs in epilepsy.
    Morselli PL
    Funct Neurol; 1986; 1(4):503-11. PubMed ID: 3609878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subjective phenomena in drug trials.
    Gagnon MA
    Int J Clin Pharmacol Biopharm; 1977 Apr; 15(4):155-60. PubMed ID: 323162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The evaluation of drugs after their commercialization].
    Laporte JR; Carné X; Porta M
    Med Clin (Barc); 1983 Nov; 81(17):772-4. PubMed ID: 6361402
    [No Abstract]   [Full Text] [Related]  

  • 14. [Protocol for the clinical pharmacology study of the hypnotic properties of a drug].
    Allain H; Milon D; van den Driessche J
    Therapie; 1984; 39(1):13-6. PubMed ID: 6463940
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug actions, drug safety and drug evaluation. A short review].
    Gross R; Fricke U
    Med Welt; 1981 Aug; 32(35):1257-63. PubMed ID: 7278602
    [No Abstract]   [Full Text] [Related]  

  • 16. [Proceddings: Are geriatric drugs beneficiary? (AUTHOR'S TRANSL)].
    Coper H; Kanowski S
    Arzneimittelforschung; 1976; 26(6):1027-8. PubMed ID: 786307
    [No Abstract]   [Full Text] [Related]  

  • 17. [Controlled drug trials from the forensic view point. Admissibility criteria of the drug law].
    Eser A
    Internist (Berl); 1982 Apr; 23(4):218-26. PubMed ID: 7045024
    [No Abstract]   [Full Text] [Related]  

  • 18. [Good clinical practice. Requirements for clinical documentation on the introduction of new drugs].
    Dirach J
    Ugeskr Laeger; 1990 Apr; 152(14):992-4. PubMed ID: 2183456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What clinical drug trials do for you.
    DiPalma JR
    RN; 1977 Jan; 40(1):67-8, 70. PubMed ID: 318760
    [No Abstract]   [Full Text] [Related]  

  • 20. [Restrictions and methodological considerations of multicenter trials (author's transl)].
    Selbmann HK
    Arzneimittelforschung; 1978; 28(11a):2023-6. PubMed ID: 383092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.